Assignee
PALATIN TECHNOLOGIES INC
US·57 granted patents·21 pending applications·577 citations·filing 1999–2022
Top patents by PatentIndex Score
78 records- 0193US7968548B2Melanocortin receptor-specific piperazine compounds with diamine groupsPALATIN TECHNOLOGIES INC·Filed 2006·Granted Jun 28, 2011·19 cites·16 claims
- 0292US7396814B2Metallopeptide compositions for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2005·Granted Jul 8, 2008·12 cites·12 claims
- 0392US6579968B1Compositions and methods for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2000·Granted Jun 17, 2003·84 cites·7 claims
- 0491US7342089B2Cyclic peptides for treatment for cachexiaPALATIN TECHNOLOGIES INC·Filed 2005·Granted Mar 11, 2008·21 cites·18 claims
- 0591US7176279B2Cyclic peptide compositions and methods for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2003·Granted Feb 13, 2007·28 cites·19 claims
- 0690US7897721B2Cyclic peptide compositions for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2009·Granted Mar 1, 2011·5 cites·30 claims
- 0789US8877890B2Melanocortin-1 receptor-specific cyclic peptidesPALATIN TECHNOLOGIES INC·Filed 2013·Granted Nov 4, 2014·8 cites·27 claims
- 0889US7345144B2Cyclic peptides for treatment of cachexiaPALATIN TECHNOLOGIES INC·Filed 2005·Granted Mar 18, 2008·15 cites·16 claims
- 0989US6794489B2Compositions and methods for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2002·Granted Sep 21, 2004·49 cites·18 claims
- 1088US7795221B2Linear natriuretic peptide constructsPALATIN TECHNOLOGIES INC·Filed 2007·Granted Sep 14, 2010·15 cites·13 claims
- 1188US7727991B2Substituted melanocortin receptor-specific single acyl piperazine compoundsPALATIN TECHNOLOGIES INC·Filed 2006·Granted Jun 1, 2010·8 cites·15 claims
- 1288US7354923B2Piperazine melanocortin-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2004·Granted Apr 8, 2008·26 cites·50 claims
- 1388US7326707B2Bicyclic melanocortin-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2004·Granted Feb 5, 2008·23 cites·56 claims
- 1487US11590209B2Use of bremelanotide in patients with controlled hypertensionPALATIN TECHNOLOGIES INC·Filed 2021·Granted Feb 28, 2023·2 cites·17 claims
- 1587US7732451B2Naphthalene-containing melanocortin receptor-specific small moleculePALATIN TECHNOLOGIES INC·Filed 2005·Granted Jun 8, 2010·6 cites·15 claims
- 1687US7718802B2Substituted melanocortin receptor-specific piperazine compoundsPALATIN TECHNOLOGIES INC·Filed 2005·Granted May 18, 2010·6 cites·34 claims
- 1787US7235625B2Multiple agent therapy for sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2005·Granted Jun 26, 2007·17 cites·22 claims
- 1886US8729224B2Melanocortin receptor-specific peptides for treatment of female sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2013·Granted May 20, 2014·7 cites·9 claims
- 1986US7709484B1Substituted melanocortin receptor-specific piperazine compoundsPALATIN TECHNOLOGIES INC·Filed 2005·Granted May 4, 2010·8 cites·19 claims
- 2086US7456184B2Melanocortin receptor-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2004·Granted Nov 25, 2008·24 cites·15 claims
- 2186US7049398B1Melanocortin metallopeptide constructs, combinatorial libraries and applicationsPALATIN TECHNOLOGIES INC·Filed 2000·Granted May 23, 2006·16 cites·54 claims
- 2285US10711039B2Melanocortin receptor-specific peptide with C-terminal naphthylalaninePALATIN TECHNOLOGIES INC·Filed 2018·Granted Jul 14, 2020·1 cites·17 claims
- 2385US10017539B2Melanocortin-1 receptor-specific cyclic hexapeptidesPALATIN TECHNOLOGIES INC·Filed 2016·Granted Jul 10, 2018·3 cites·20 claims
- 2485US7727990B2Melanocortin receptor-specific piperazine and keto-piperazine compoundsPALATIN TECHNOLOGIES INC·Filed 2006·Granted Jun 1, 2010·6 cites·20 claims
- 2584US9447148B2Melanocortin-1 receptor-specific cyclic peptidesPALATIN TECHNOLOGIES INC·Filed 2014·Granted Sep 20, 2016·4 cites·30 claims
- 2684US7795378B2Peptide compositions for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2005·Granted Sep 14, 2010·5 cites·4 claims
- 2783US7964601B2Melanocortin receptor-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2008·Granted Jun 21, 2011·6 cites·17 claims
- 2883US7385025B2Metallopeptide compoundsPALATIN TECHNOLOGIES INC·Filed 2005·Granted Jun 10, 2008·2 cites·10 claims
- 2983US6331285B1Structurally determined cyclic metallo-constructs and applicationsPALATIN TECHNOLOGIES INC·Filed 1999·Granted Dec 18, 2001·61 cites·16 claims
- 3082US7622440B2Cyclic natriuretic peptide constructsPALATIN TECHNOLOGIES INC·Filed 2007·Granted Nov 24, 2009·6 cites·24 claims
- 3182US7473760B2Cyclic peptide compositions for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2005·Granted Jan 6, 2009·16 cites·9 claims
- 3281US7754691B1Linear melanocortin receptor-specific peptides for cachexiaPALATIN TECHNOLOGIES INC·Filed 2006·Granted Jul 13, 2010·3 cites·13 claims
- 3381US7655658B2Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2005·Granted Feb 2, 2010·4 cites·15 claims
- 3481US7097824B2Tuftsin metallopeptide analogs and uses thereofPALATIN TECHNOLOGIES INC·Filed 2003·Granted Aug 29, 2006·8 cites·17 claims
- 3580US10106578B2Melanocortin-1 receptor-specific linear peptidesPALATIN TECHNOLOGIES INC·Filed 2017·Granted Oct 23, 2018·2 cites·7 claims
- 3680US7834017B2Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituentsPALATIN TECHNOLOGIES INC·Filed 2007·Granted Nov 16, 2010·5 cites·10 claims
- 3780US7550602B1Small molecule compositions for sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2005·Granted Jun 23, 2009·2 cites·9 claims
- 3880US7189755B2Pyrrolidine melanocortin-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2004·Granted Mar 13, 2007·9 cites·12 claims
- 3978US7807678B2Peptidomimetics of biologically active metallopeptidesPALATIN TECHNOLOGIES INC·Filed 2004·Granted Oct 5, 2010·8 cites·2 claims
- 4078US7417027B2Linear and cyclic melanocortin receptor-specific peptidesPALATIN TECHNOLOGIES INC·Filed 2004·Granted Aug 26, 2008·12 cites·8 claims
- 4178US2022362328A1Uses of bremelanotide in therapy for female sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 4277US7307063B2Melanocortin metallopeptides for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2003·Granted Dec 11, 2007·7 cites·12 claims
- 4376US10286034B2Uses of bremelanotide in therapy for female sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2017·Granted May 14, 2019·1 cites·17 claims
- 4476US7425608B2Method of making metallopeptidesPALATIN TECHNOLOGIES INC·Filed 2005·Granted Sep 16, 2008·1 cites·4 claims
- 4575US7964181B2Amino acid surrogates for peptidic constructsPALATIN TECHNOLOGIES INC·Filed 2007·Granted Jun 21, 2011·1 cites·35 claims
- 4674US12459894B2Orally active melanocortin receptor-4 compoundsPALATIN TECHNOLOGIES INC·Filed 2022·Granted Nov 4, 2025·0 cites·7 claims
- 4774US11286280B2Melanocortin-1 receptor-specific peptides for cytokine storm and inflammation therapyPALATIN TECHNOLOGIES INC·Filed 2020·Granted Mar 29, 2022·0 cites·10 claims
- 4874US7601753B2Pyrrolidine melanocortin-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2007·Granted Oct 13, 2009·1 cites·17 claims
- 4973US9580466B2Melanocortin-1 receptor-specific linear peptidesPALATIN TECHNOLOGIES INC·Filed 2014·Granted Feb 28, 2017·1 cites·5 claims
- 5072US9458201B2Melanocortin receptor-specific heptapeptidesPALATIN TECHNOLOGIES INC·Filed 2014·Granted Oct 4, 2016·0 cites·16 claims
Showing the top 50 of 78 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →